Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2020

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

ILIT with extract of causal allergen

0.5 ml of allergen extract from D. farinae, D. pteronyssinus, cat, and/or dog for allergen specific immunotherapy (Tyrosine S, Allergy Therapeutic, UK) will be injected into inguinal lymph node through guidance by ultrasonography three times with 4-week interval.

BIOLOGICAL

ILIT with normal saline

0.5 ml of normal saline will be injected into inguinal lymph node through guidance by ultrasonography three times with 4-week interval.

DRUG

Rescue medication for allergic rhinitis

Subjects are requested to administer oral antihistamine (cetirizine) or nasal glucocorticosteroid (ciclesonide) as rescue medication for allergic rhinitis in accordance with severity and frequency of allergic rhinitis symptoms according to Allergic Rhinitis and its Impact on Asthma (ARIA) guideline.

Trial Locations (1)

405-760

Gachon University Gil Medical Center, Incheon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Korea Research Foundation

OTHER

lead

Gachon University Gil Medical Center

OTHER